The January 2025 issue of Nature includes an article on the NIH-funded dGTEx project, titled, "The Human and Non-human Primate Developmental GTEx Projects." It outlines the scope, vision, ...

US biotech Voyager Therapeutics saw its shares close down 21% at $4.20 on Tuesday, after it revealed its decision to assess ...

Researchers developed an epigenetic editing approach to silence the PCSK9 gene, achieving long-term cholesterol reduction ...

A bill before the legislature would ensure a peaceful, pain-free life for primates no longer needed for medical testing, ...

University of Wisconsin researchers and collaborators recently published a feasibility study that focuses on limiting fetal growth restriction in nonhuman primates through nanoparticle injections of ...

Inc. has seen its stock tumble to a 52-week low, touching down at $1.12. With a current market capitalization of just $93 million, the company maintains a strong liquidity position with a current ...